Skip to main content
SpringerLink
Log in

Ustekinumab: associated with vasculitis?

  • Incidence study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. WHO Global Individual Case Safety Report Database

  2. Canada, Greece, Spain, UK and USA

References

  1. Uppsala Monitoring Centre. Ustekinumab and Vasculitis. WHO Pharmaceuticals Newsletter : 18-21, No. 3, Jun 2014.

  2. Janssen. Response from Janssen (re: Ustekinumab and Vasculitis). WHO Pharmaceuticals Newsletter : 21-23, No. 3, Jun 2014.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ustekinumab: associated with vasculitis?. Reactions Weekly 1508, 3 (2014). https://doi.org/10.1007/s40278-014-1637-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-014-1637-6

Search

Navigation